What is the role of NGS in triple-negative breast cancer? Are there actionable insights than emerge from full exome sequencing in patients with TNBC who have progressed on standard therapies?

What is the role of NGS in triple-negative breast cancer? Are there actionable insights than emerge from full exome sequencing in patients with TNBC who have progressed on standard therapies?

What is the role of NGS in patients with triple-negative breast cancer? Is it controversial? Are there actionable insights than emerge from full exome sequencing in patients with TNBC who have progressed on standard therapies?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Specialist in Medical Oncology
Hon. Clinical Assistant Professor
Li Ka Sing Faculty of Medicine
The University of Hong Kong